Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Colorectal cancer

Back to the stroma—the real villain in colorectal cancer?

The cells responsible for particular gene signatures in large-scale microarray studies of colorectal cancer have now been revealed. In doing so, the gene signature associated with poor prognosis is shown to be predominantly of stromal origin.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Gene signatures and stromal epithelial interactions in colorectal cancer.

References

  1. Calon, A. et al. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer. Nat. Genet. 47, 320–329 (2015).

    Article  CAS  PubMed  Google Scholar 

  2. Isella, C. et al. Stromal contribution to the colorectal cancer transcriptome. Nat. Genet. 14, 312–319 (2015).

    Article  Google Scholar 

  3. Finak, G. et al. Stromal gene expression predicts clinical outcome in breast cancer. Nat. Med. 14, 518–527 (2008).

    Article  CAS  PubMed  Google Scholar 

  4. Nishida, N. et al. Microarray analysis of colorectal cancer stromal tissue reveals upregulation of two oncogenic miRNA clusters. Clin. Cancer Res. 18, 3054–3070 (2012).

    Article  CAS  PubMed  Google Scholar 

  5. Patocs, A. et al. Breast-cancer stromal cells with TP53 mutations and nodal metastases. N. Engl. J. Med. 357, 2543–2551 (2007).

    Article  CAS  PubMed  Google Scholar 

  6. Ngan, C. Y. et al. Quantitative evaluation of vimentin expression in tumour stroma of colorectal cancer. Br. J. Cancer 96, 986–992 (2007).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Bhowmick, N. A. et al. TGF-β signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science 303, 848–851 (2004).

    Article  CAS  PubMed  Google Scholar 

  8. Calon, A. et al. Dependency of colorectal cancer on a TGF-β-driven program in stromal cells for metastasis initiation. Cancer Cell 22, 571–584 (2012).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Karnoub, A. E. et al. Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449, 557–563 (2007).

    Article  CAS  PubMed  Google Scholar 

  10. Todaro, M. et al. CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. Cell Stem Cell 14, 342–356 (2014).

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgements

The authors would like to thank H. Yamamoto, N. Nishida, A. Hamabe and H. Ishii for their intellectual input.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Masaki Mori.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Colvin, H., Mori, M. Back to the stroma—the real villain in colorectal cancer?. Nat Rev Gastroenterol Hepatol 12, 256–258 (2015). https://doi.org/10.1038/nrgastro.2015.57

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2015.57

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer